Search - tctmd.com

Displaying 101 - 120 of 135

Sort: Relevancy | Date

Presentation SWVS 2017

The New ASE Guidelines for Native Valvular Regurgitation

Presenter: William A. Zoghbi

May 05, 2017

News Daily News

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Michael O'Riordan

May 04, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

Podcast Heart Sounds

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

April 26, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

Presentation ECHO 2017

Assessing Prosthetic Valve Function: Differentiating Normal From Stenotic or Regurgitant

Presenter: Philippe Pibarot

April 01, 2017

Presentation ECHO 2017

Nuances of Aortic Regurgitation Assessment

Presenter: Rebecca T. Hahn

April 01, 2017

Presentation ECHO 2017

Strengths and Weaknesses of Mitral Regurgitation Quantification: Is There a Difference Between Primary and Secondary?

Presenter: Linda D. Gillam

April 01, 2017

Presentation ECHO 2017

Clinical Cases: Echocardiographic Guiding in a Catheter Based Treatment of Severe Functional Mitral Regurgitation

Presenter: Florian Deuschl

March 31, 2017

Presentation ECHO 2017

Echo Hemodynamics II: Echo Quantification of Valvular Regurgitation

Presenter: Linda D. Gillam

March 31, 2017

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Daily News

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

Yael L. Maxwell

March 27, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Daily News

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

Todd Neale

March 14, 2017

Presentation SIF 2017

Learning From the Experts: A Review of Degenerative, Functional and Mixed Etiology Mitral Regurgitation

Presenter: Robert F. Burke

March 09, 2017

News Conference News CRT 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Michael O'Riordan

February 27, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Advertisement

The New ASE Guidelines for Native Valvular Regurgitation

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

LivaNova Acquires Caisson Interventional, LLC

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Top Stories in Cardiology, April 2017

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Assessing Prosthetic Valve Function: Differentiating Normal From Stenotic or Regurgitant

Nuances of Aortic Regurgitation Assessment

Strengths and Weaknesses of Mitral Regurgitation Quantification: Is There a Difference Between Primary and Secondary?

Clinical Cases: Echocardiographic Guiding in a Catheter Based Treatment of Severe Functional Mitral Regurgitation

Echo Hemodynamics II: Echo Quantification of Valvular Regurgitation

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

Learning From the Experts: A Review of Degenerative, Functional and Mixed Etiology Mitral Regurgitation

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content